Meg21

Experience the immediate “glow” and dry skin relief!

Dramatic results reducing the appearance of wrinkles and fine lines within 4 weeks!

Feel it! See it! Love it!

At Fox Chase Research Center, a ground-breaking treatment to reduce the signs of aging was the last thing the Dynamis Diabetes research team was expecting. But, scientific serendipity struck while they were seeking a way to prevent glycation, a cause of diabetic complications such as blindness and nerve damage. Glycation occurs when sugars in the body react with (and damage) proteins. One of the worst results is the creation of 3-deoxyglucosone (3DG), which is responsible for much of the damage.

Most often 3DG gets sweated out of the skin but some remains behind and overtime, causes skin damage.  Laboratory research demonstrates that 3DG is present in skin and causes:

• inflammation
• decreased production of collagen
• collagen and elastin cross-linking
• formation of Advanced Glycation End products (AGEs)
• oxidative stress and free radicals

But glycation is not limited to diabetics — it happens in everyone’s body and is in skin! The resulting glycated proteins tend to fuse together in a process called cross-linking causing a loss of elasticity and hardening of collagen in the skin. The older we get, and the more sugars we consume, the more glycation damages our skin.

Dynamis scientists had a breakthrough: They found a compound that slows the production of 3DG. The formula worked — but in the process, they discovered an unintended benefit. The skin of subjects using the compound was smoother and softer, with improved elasticity. Subjects also noticed a reduction in the appearance of lines and wrinkles.

Dynamis brings its discovery out of the laboratory with MEG 21 — a unique skin treatment that delivers the compound Supplamine® deep into skin to reduce inflammation and free radicals, allow normal collagen production and reverse cross-linking.

The Philadelphia Inquirer features MEG21